MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0082653
VHB Life Sciences Limited - pharma in Kandivlai West, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹13.99 Cr
▼ 74% YoY
Net loss · FY 2025
₹2.03 Cr
Net margin -14.5%
EBITDA · FY 2025
-₹1.68 Cr
EBITDA margin -12%
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹12.7 Cr
Issued & subscribed
Open charges
₹4 Cr
Satisfied ₹61.25 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
7
Provident fund records
About VHB Life Sciences Limited
Data last updated:
VHB Life Sciences Limited is a public limited company based in Kandivlai West, Maharashtra, India, a subsidiary of Neon Laboratories Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 June 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2007PLC171648. Its GSTIN is 27AACCV5103A1ZX (Maharashtra).
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹12.7 Cr. It is led by directors including Pravin Jain (Whole-Time Director) and Ashokkumar Keshrimal Jain.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 30 A Government Industrial Estate, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.99 Cr, a decline of 74% compared to the previous year. For the same year it recorded a net loss of ₹2.03 Cr (net margin -14.5%) and EBITDA of -₹1.68 Cr (EBITDA margin -12%). Revenue has declined at a compounded annual rate (CAGR) of 52% over three years and 30% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: VHB Life Sciences. As per MCA filings, the company has open charges of ₹4 Cr and satisfied charges of ₹61.25 Cr on record. Court records list 86 cases involving the company, including 54 filed by the company and 32 filed against it; 9 cases are pending. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹12.65 Cr; the latest was in March 2015. Its 5 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 2 smaller; the largest is SBS Biotech Corporate Private Limited with revenue of ₹14.08 Cr.
VHB Life Sciences Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0082653). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vhbgroup.com.
Company details
CIN U74900MH2007PLC171648
Registration Number 171648
Incorporation Date 13 June 2007
ROC Mumbai
Listing Status Unlisted
Company Status Active
Parent Company Neon Laboratories Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0082653
Key People
Pravin Jain Whole-Time Director Ashokkumar Keshrimal Jain Director Uttamchand Kesharimal Jain Director Recognitions & Rankings of VHB Life Sciences
Contact details
VHB Life Sciences Limited's registered office is in Kandivlai West, Maharashtra. Its website is vhbgroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address30 A Government Industrial Estate, Charkop Kandivali (West) Mumbai Maharashtra India Pin 400067, Kandivlai West, Maharashtra, India – 400067
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of VHB Life Sciences Limited, buy the company report.
Comprehensive company report
VHB Life Sciences Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
VHB Life Sciences operates one associated brand: VHB Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generics and APIs are manufactured across therapeutic segments. | vhbgroup.com |
Business activity
The main business activity of VHB Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of VHB Life Sciences Limited, buy the company report.
Financials of VHB Life Sciences Limited
FY 2025 filings availableVHB Life Sciences Limited reported revenue of ₹13.99 Cr (down 74% YoY) for FY 2025.
Revenue · FY 2025
₹13.99 Cr ▼ 74%
Net loss · FY 2025
₹2.03 Cr margin -14.5%
EBITDA · FY 2025
-₹1.68 Cr margin -12%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 74%
3 years · compounded
▼ 52%
5 years · compounded
▼ 30%
EBITDA CAGR growth
1 year
▼ 159%
3 years · compounded
▼ 28%
5 years · compounded
▲ 50%
Revenue has declined at a compounded annual rate (CAGR) of 30% over five years, including a 74% fall in the latest year. EBITDA fell 159% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.68 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.03 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -12% | ||||
| Net Profit Margin | -14.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of VHB Life Sciences Limited, buy the company report.
Board of directors of VHB Life Sciences Limited
VHB Life Sciences has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pravin Jain Also directs: Neon Laboratories Limited, VHB Pharmaceuticals Private Limited, VHB Medi Sciences Limited and 5 more | Whole-Time Director | 27 Sep 2012 | 14 Years 1 Months | Current |
| Ashokkumar Keshrimal Jain Also directs: Neon Laboratories Limited, Axiommax Oncology Private Limited, Surajlok Chemicals Private Limited and 3 more | Director | 27 Sep 2012 | 14 Years 1 Months | Current |
| Uttamchand Kesharimal Jain Also directs: Neon Laboratories Limited, Axiommax Oncology Private Limited, VHB Pharmaceuticals Private Limited and 5 more | Director | 27 Sep 2012 | 14 Years 1 Months | Current |
| Rahul Ashokkumar Jain Also directs: Surajlok Chemicals Private Limited, VHB Medi Sciences Limited, Sndev Healthcare Limited and 1 more | Director | 27 Sep 2012 | 14 Years 1 Months | Current |
Peer comparison
VHB Life Sciences Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SBS Biotech Corporate Private Limited | ₹14.08 Cr (FY 2024) | 2.0% | Ambala Cantt, Haryana, India | |||
| Cannyco Pharma Private Limited | ₹14.07 Cr (FY 2023) | 10.0% | New Delhi, Delhi, India | |||
| Elder-Ici Healthcare Private Limited | ₹14.04 Cr (FY 2024) | -12.0% | Daman, Dadra and Nagar Haveli, India | |||
| VHB Life Sciences Limitedthis company | ₹13.99 Cr (FY 2025) | -₹2.03 Cr | -14.5% | -74.0% | 7 | Kandivlai West, Maharashtra, India |
| Shire Biotech India Private Limited | ₹13.91 Cr (FY 2022) | 24.0% | Gurgaon, Haryana, India | |||
| Trinity Pharmaceuticals & Food Private Limited | ₹13.88 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of VHB Life Sciences Limited, buy the company report.
Auditor
VHB Life Sciences Limited is audited by RAJU MORE & ASSOCIATES CHARTERED ACOUNTANTS for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJU MORE & ASSOCIATES CHARTERED ACOUNTANTS | FY 2023 | 127718W |
Shareholding
The shareholding of VHB Life Sciences Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of VHB Life Sciences Limited, buy the company report.
Charges & borrowings
Open charges
₹4 Cr
Satisfied charges
₹61.25 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Apr 2008 | 10105747 | Others | ₹2 Cr | Open | |
| 06 Sep 2007 | 10070356 | Others | ₹2 Cr | Open | |
| 09 Sep 2014 | 10531178 | Bank of Baroda | ₹58 Cr | Satisfied | |
| 18 Feb 2009 | 10148576 | Bank of Baroda | ₹1.25 Cr | Satisfied | |
| 04 Jul 2008 | 10118670 | Bank of Baroda | ₹2 Cr | Satisfied |
To see the full charge records of VHB Life Sciences Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
VHB Life Sciences Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹12.65 Cr; the latest was in March 2015.
Total deals
4
Secondary share transfers
3
Funding round
1
Disclosed funding
₹12.65 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: Neon Laboratories Limited & Ashok K Jain, Neon Laboratories Limited & Pravin K Jain HUF, Neon Laboratories Limited & Uttam K Jain HUF Seller: Uttam Keshrimal Jain HUF, Ashok Keshrimal Jain HUF, 2 individuals |
| Oct 2011 | Secondary share transfer | Undisclosed | Buyer: Ashok Keshrimal Jain HUF, Uttam Keshrimal Jain HUF, 2 individuals Seller: 4 individuals |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: Neon Laboratories Limited Seller: 4 individuals |
| Feb 2009 | Funding round | ₹12.65 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
VHB Life Sciences Limited has 86 court cases on record: 54 filed by VHB Life Sciences, 32 filed against it. 9 cases are pending and 77 are disposed.
Total cases
86
Filed by the company
54
Filed against the company
32
Pending
9
Disposed
77
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 55 | 18 | 3 |
| District courts | 26 | 13 | 6 |
| Supreme Court | 5 | 1 | 0 |
Cases on record (5 of 86)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Akums Drugs & Pharmaceuticals Ltd | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Laborate Pharmaceuticals India Ltd | Disposed |
| Supreme Court | Court case (1100-Arbitration Matters : SLPs challenging Arbitration Matters) | Filed by the company against Orchid Pharma Ltd. (Formerly Known As Orchid Chemicals and Pharmaceuticals) Managing Director Managing Director Orchid Towers No 313, Valluvarkottam High Road , District: Nungambakkam Chennai ,Chennai , Tamil Nadu | Disposed |
| High Court of Delhi | Arbitration matter | Filed against the company by Orchid Pharma Limited | Disposed |
| Bombay High Court | Court case (S) | Filed by the company against M/S. Zaneka Healthcare Ltd. and Anr. | Disposed |
To see the full case history of VHB Life Sciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
VHB Life Sciences Limited was last rated by Crisil on 30 Jul 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 30 Jul 2020 |
To see the full credit ratings and regulatory alerts of VHB Life Sciences Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for VHB Life Sciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
VHB Life Sciences Limited has a workforce of 7 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
7
Active EPFO establishments
1
Employee growth
-89.2%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 7 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of VHB Life Sciences Limited, buy the company report.
GST
VHB Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCV5103A1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of VHB Life Sciences Limited, buy the company report.
Recent activity
VHB Life Sciences Limited has 20 board changes on record since 2007: 12 appointments and 8 cessations. The latest: Abhay Uttamchand Jain ceased to be CFO on 01 Jul 2019.
AGM
Vhb Life Sciences Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
Vhb Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge registered on 09 Sep 2014 via Charge ID 10531178 with Bank Of Baroda was fully satisfied on 02 Mar 2022.
Charges
A charge with Others of Rs. 2.00 Cr registered on 08 Apr 2008 with Charge ID 10105747 was modified on 19 Apr 2021.
Charges
A charge with Others of Rs. 2.00 Cr registered on 06 Sep 2007 with Charge ID 10070356 was modified on 19 Apr 2021.
Charges
A charge registered on 18 Feb 2009 via Charge ID 10148576 with Bank Of Baroda was fully satisfied on 24 Oct 2019.
Charges
A charge registered on 04 Jul 2008 via Charge ID 10118670 with Bank Of Baroda was fully satisfied on 24 Oct 2019.
Ceased
Abhay Uttamchand Jain ceased to be CFO.
Ceased
Kishor Champalal Solanki ceased to be Director.
Ceased
Pradip Chotabhai Patel ceased to be Director.
Appointed
Abhay Uttamchand Jain was appointed as CFO.
Appointed
Pradip Chotabhai Patel was appointed as Director.
21 earlier events are in the company report.
Frequently asked questions
VHB Life Sciences is an active public limited company based in Kandivlai West, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 June 2007 (19+ years old) and is registered under CIN U74900MH2007PLC171648.
VHB Life Sciences has 4 current directors:
- Pravin Jain - Whole-Time Director
- Ashokkumar Keshrimal Jain - Director
- Uttamchand Kesharimal Jain - Director
- Rahul Ashokkumar Jain - Director
The latest financial statements of VHB Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of VHB Life Sciences is 27AACCV5103A1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of VHB Life Sciences is U74900MH2007PLC171648. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
VHB Life Sciences has 86 court cases on record: 54 filed by the company and 32 filed against it. 9 are pending. Most are in the high courts.
VHB Life Sciences was incorporated on 13 June 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
VHB Life Sciences has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹12.65 Cr; the latest was in March 2015.
The peers of VHB Life Sciences by revenue are SBS Biotech Corporate Private Limited, Cannyco Pharma Private Limited, Elder-Ici Healthcare Private Limited, Shire Biotech India Private Limited, Trinity Pharmaceuticals & Food Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Abhay Uttamchand Jain ceased to be CFO on 01 Jul 2019. Kishor Champalal Solanki ceased to be Director on 31 Jul 2018. Pradip Chotabhai Patel ceased to be Director on 31 Jul 2018. VHB Life Sciences has 20 board changes on record in total.
Yes, VHB Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0082653).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages